rac-5-Hydroxymethyl Tolterodine D14
| Product Name | rac-5-Hydroxymethyl Tolterodine D14 |
|---|---|
| Alternate Names | Tolterodine Stable Isotopes, Stable Isotopes of Tolterodine |
| CAT No. | CS-O-16008 |
| CAS No. | 1185071-13-9 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 355.6 g/mol |
| Mol. For. | C22H17D14NO2 |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Tolterodine |
| Purity | 95% |
| Smileys | OC1=CC=C(CO)C=C1C(C2=CC=CC=C2)CCN(C(C([2H])([2H])[2H])([2H])C([2H])([2H])[2H])C(C([2H])([2H])[2H])([2H])C([2H])([2H])[2H] |
| Canonical Smiles | CC(C)N(CCC(C1=CC=CC=C1)C2=C(C=CC(=C2)CO)O)C(C)C |
| InchIKey | DUXZAXCGJSBGDW-UWDFEEFGSA-N |
| Inchl | InChI=1S/C22H31NO2/c1-16(2)23(17(3)4)13-12-20(19-8-6-5-7-9-19)21-14-18(15-24)10-11-22(21)25/h5-11,14,16-17,20,24-25H,12-13,15H2,1-4H3/i1D3,2D3,3D3,4D3,16D,17D |
| IUPAC | 2-[3-[bis(1,1,1,2,3,3,3-heptadeuteriopropan-2-yl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenol |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Rac-5-Hydroxymethyl Tolterodine D14, also known as 5-HMTD14, is a chemical compound used in the treatment of overactive bladder syndrome. This medication works by blocking the action of a neurotransmitter called acetylcholine, which is responsible for muscle contractions in the bladder. By blocking the action of this neurotransmitter, 5-HMTD14 helps to relax the muscles of the bladder, reducing the frequency and urgency of urination.
Chemically, 5-HMTD14 is a deuterated analog of 5-HMT, which means that it contains 14 deuterium atoms instead of the standard hydrogen atoms found in the non-deuterated compound. This modification allows for more precise analysis of the drug's metabolic pathways and enhances its stability within the body.
The recommended dosage of 5-HMTD14 is typically 4mg per day, taken orally with or without food. It is important to follow the instructions of a healthcare provider when taking this medication, as improper use can result in side effects such as dry mouth, constipation, and blurred vision.
Overall, Rac-5-Hydroxymethyl Tolterodine D14 is a useful medication for the treatment of overactive bladder syndrome, with a well-established mechanism of action and relatively low incidence of side effects.
Get an Instant Quote
Related Compounds
rac Desisopropyl Tolterodine D7 | Tolterodine Tartrate D14 | rac Tolterodine D14 tartrate | rac 5-Carboxy Tolterodine-d14 | rac Tolterodine-d6 Hydrochloride | rac 5-Carboxy Desisopropyl Tolterodine-d7 Methyl Ester | rac 5-Hydroxymethyl Desisopropyl Tolterodine-d6 | Tolterodine D14 hydrochloride | rac Desisopropyl Tolterodine-d7 Methyl Ether | rac Tolterodine D14 Hydrochloride | rac 5-Carboxy Desisopropyl Tolterodine-d7 |